Menu Back to 15th-DIA-Japan-Annual-Meeting-2018

Overview

How do countries across the globe collaborate effectively to deliver innovative pharmaceutical products, medical devices, and regenerative medical products to patients, in the fastest, most efficient way possible?

With healthcare product development becoming increasingly global, the time has come to deepen the discussion on how to leverage the individual strengths of countries, promote better collaboration, and strengthen global partnerships, to build the ideal system for creating medicines, medical devices, and regenerative medical products.

Further, innovative technologies such as artificial intelligence, big data/genomics, and cell/gene therapies are poised to transform healthcare product development across the globe – join us as at the DIA Japan Annual Meeting 2018, to discuss these topics and the future of healthcare.

We look forward to welcoming you at Tokyo Big Sight from November 11-13, 2018 for stimulating discussions around promoting better collaboration to drive global health and innovation in this era of medical and scientific transformation.

We hope to see you there!

Program Committee

  • Takuko  Sawada
    Takuko Sawada Director of the Board, Executive Vice President
    Shionogi & Co., Ltd., Japan
  • Kazuhiro  Kanmuri, PhD
    Kazuhiro Kanmuri, PhD Director/CEO
    CTD Inc./inter-Professional Inc., Japan
  • Taro  Amagasaki, PhD
    Taro Amagasaki, PhD Department Head, Integrated Biostatistics Japan Department
    Novartis Pharma K.K., Japan
  • Noriko  Fujiwara, MS, RN
    Noriko Fujiwara, MS, RN Research Nurse, Project Researcher, Department of Palliative Medicine
    IMSUT Hospital, The Institute of Medical Science, The University of Tokyo, Japan
  • Yoshikata  Furuya, MSc
    Yoshikata Furuya, MSc Director, Vaccine Policy, Health Policy
    MSD K.K., Japan
  • Shinzo  Hiroi, PhD, MPH, RPh, PMP
    Shinzo Hiroi, PhD, MPH, RPh, PMP Head of Global Medical Affairs
    Shionogi & Co., Ltd., Japan
  • Kazuo  Ichikawa, PhD, PMP
    Kazuo Ichikawa, PhD, PMP Senior Staff Adviser, Group II, Global Project Management Department, R&D Div.
    Daiichi Sankyo Co., Ltd., Japan
  • Katsuhiko  Ichimaru
    Katsuhiko Ichimaru Office of Review Management
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Akiko  Ikeda, RPh
    Akiko Ikeda, RPh Senior Manager, Policy Intelligence Dept., Integrated Market Access Division
    Janssen Pharmaceutical K.K., Japan
  • Toshiko  Ishibashi, PhD, RN
    Toshiko Ishibashi, PhD, RN Associate Clinical Operations Manager, Japan Site Management & Monitoring
    AbbVie GK, Japan
  • Kazuhiko  Ishida, MSc, RPh
    Kazuhiko Ishida, MSc, RPh Associate Director, Pharmacovigilance
    Astellas Pharma Inc., Japan
  • Miyuki  Kaneko
    Miyuki Kaneko Manager, Japan Regulatory Lead
    Pfizer Japan Inc., Japan
  • Yoko  Kazami, PMP
    Yoko Kazami, PMP Manager
    Nobelpharma Co., Ltd., Japan
  • Noriatsu  Kono
    Noriatsu Kono Senior Director, Global Project Management
    Japan Agency for Medical Research and Development (AMED), Japan
  • Yukihiro  Matsuda, MSc
    Yukihiro Matsuda, MSc Research Scientist, Trial Mgmt., Clinical Development Operations & Innovatiion
    Eli Lilly Japan K.K., Japan
  • Yasutsugu  Nakano
    Yasutsugu Nakano Sr. Director, Head of Development Regulatory Affairs 2, Regulatory Affairs Dept.
    Shionogi & Co., Ltd., Japan
  • Motohide  Nishi, MBA
    Motohide Nishi, MBA Vice President, Asia Pacific Technology
    Medidata Solutions K.K., Japan
  • Minori  Niso
    Minori Niso Acute Care Diagnostics Product Manager, Instrumentation Laboratory
    I.L. Japan Co., Ltd., Japan
  • Atsushi  Noguchi, MS
    Atsushi Noguchi, MS Reviewer, Office of New Drug V
    Pharmaceuticals and Medical Devices Agency, Japan
  • Kimiya  Okazaki, PharmD, PhD
    Kimiya Okazaki, PharmD, PhD Associate Department Manager, Regulatory Intelligence, Regulatory Affairs
    GlaxoSmithKline K.K., Japan
  • Mikiko  Shitara
    Mikiko Shitara Team Leader, Labeling Dept., RA, Development & Medical Affairs Div.
    GlaxoSmithKline K.K., Japan
  • Kuniko  Shoji
    Kuniko Shoji Director and Corporate Advisor
    Terumo Corporation, Japan
  • Keiko  Tsumori
    Keiko Tsumori Associate Director, Medical Writing, Regulatory Affairs Area, Japan Development
    MSD K.K., Japan
  • Tadashi  Urashima, PhD
    Tadashi Urashima, PhD Manager (Strategy Deployment and Digital Practices), MA Excellence Dept.
    GlaxoSmithKline K.K., Japan
  • Koichiro  Yuji, MD, PhD, FACP
    Koichiro Yuji, MD, PhD, FACP Project Associate Professor, The Institute of Medical Science
    The University of Tokyo, Japan
  • Junichi  Nishino, MSc, RPh
    Junichi Nishino, MSc, RPh Head, RA Functions Department, Regulatory Office Japan
    Novartis Pharma K.K., Japan
  • Junko  Sato, PhD
    Junko Sato, PhD Office Director, Office of International Cooperation
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Atsushi  Tsukamoto, PhD
    Atsushi Tsukamoto, PhD Vice President, New Drug Regulatory Affairs
    Daiichi Sankyo Co., Ltd., Japan
Load More

Contact us


Registration Questions?

Send Email
+81.3.6214.0574
+81.3.3278.1313